查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球外导管市场-2022-2029
市场调查报告书
商品编码
1140746

全球外导管市场-2022-2029

Global External Catheter Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 170 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场动态

由于尿失禁增加，对外部导管的需求增加

尿失禁是尿液的意外排出。它是由尿道括约肌的控制减少或减弱引起的。它可能发生在压力源（如咳嗽）期间、母乳喂养期间或之后，并且在肥胖等情况下更为常见。根据美国泌尿学协会的数据，美国有一半到三分之一的男性和女性患有尿失禁。此外，尿失禁影响全球约 2 亿人。根据疾病控制和预防中心的数据，美国大约 75% 的医院获得性尿石与导尿管相连。根据美国泌尿外科协会的报告，美国四分之一到三分之一的男性和女性患有尿失禁。大约 3300 万人患有膀胱过度活动症 (OAB)，其特点是尿急、尿频和急迫性尿失禁。 OAB 是一种尿失禁，也称为“急迫性”尿失禁。 OAB 是一种威胁生命的疾病，在美国影响超过 30% 的男性和 40% 的女性。

在预测期内，由于全球对微创手术和设备的需求不断增加，以及公众意识和可负担性高，尤其是在新兴经济体，男性体外导管市场将增长。预计将被拖走。此外，慢性病、心血管疾病、泌尿系统疾病和糖尿病的患病率上升，正在增加整个医疗保健行业对导管的需求。

然而，体外导管的洩漏问题阻碍了市场的增长。体外导管经常使用，因此会洩漏。这就是为什么医生和医疗保健专业人员更喜欢间歇性导管等选项的原因。与使用外部导管相关的并发症是预计在预测期内抑制全球市场增长的关键因素。

地理渗透。

北美将是预测期内的主要地区。

该研究按地区分析了全球市场的外部导管市场，包括北美、欧洲、亚太地区、南美、中东和非洲。

北美将在 2021 年主导全球外部导管市场。在北美，预计美国在预测期内将出现大幅增长。该国完善的医疗保健基础设施和高昂的人均医疗费用为外部导管创造了巨大的市场。据估计，美国每 6 名男性中就有 1 名出现某种形式的尿失禁。这增加了对导管的需求并推动了市场增长。

预计亚太地区在预测期内的价值也将出现显着增长。预计对研发和先进产品开发的大量投资将推动该地区的市场增长。由于人口众多，主要在印度和中国，预计亚太地区外部导管市场在预测期内将出现快速增长。

竞争格局。

由于主要医疗公司的存在，外部导管市场是一个竞争激烈的市场。对全球市场增长做出贡献的主要公司有 B. Braun Melsungen AG、ConvaTec Healthcare B S.a.r.l、Coloplast Ltd.、Cook Medical、Teleflex Incorporated、Medline Industries Inc、Medtronic、C. R. Bard Inc、Adapta Medical、Becton Dickson Company 等。主要参与者正在为外部导管市场的全球增长采用新产品发布和扩张战略。 2020 年 9 月，巴德以 30 毫米的价格收购了一家名为 PureWick 的女性外置导管公司。该交易包括产品消耗品和中央供应。 2021年9月，B.Braun Melsungen AG完成对Sterinova Inc.的收购，获得100%的股权。 Sterinova Inc. 继续作为 B.Braun Melsungen AG 的独立子公司运营。 2020 年 11 月，世界领先的医疗器械和药品製造商之一 B.Braun Melsungen AG 和世界领先的血浆衍生药物製造商之一併为医院、诊所和药房中心提供技术和服务的 Grifols 宣布他们将建立药房业务。宣布全球扩张以提高产量和治疗安全性。两家公司都为安全的药物输送提供自动化解决方案。两家公司将专注于欧洲的商机，并逐步在其他市场推出联合服务。

COVID-19 的影响。全球外置导管市场稳定增长

由于非 COVID-19 相关的医疗保健设施以正常速度运行，预计全球对外部导管的需求增长将在整个 COVID-19 流行期间保持稳定。在当前的 COVID-19 大流行之后，预计外部导管市场将保持稳定。市场进入者被要求专注于解决 COVID-19 大流行带来的供应链挑战并设计适当的解决方案。

全球外置导管市场报告包含大约 61 个市场数据表、52 个图表和 170 页

内容

第 1 章研究方法与范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

  • 按类型划分的市场细分
  • 按应用划分的市场细分
  • 最终用户的市场细分
  • 按地区划分的市场细分

第 4 章市场动态

  • 市场影响因素
    • 促进因素
      • 尿失禁增加
      • 慢性病增加
    • 抑制因素
      • 体外导管洩漏问题
    • 影响分析

第 5 章行业分析

  • 波特五力分析
  • 供应链分析
  • 价值链分析
  • PEST 分析
  • 定价分析
  • 监管分析
  • 保险报销分析
  • 未满足的需求
  • 专利趋势

第 6 章 COVID-19 分析

  • COVID-19 的市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章按类型

  • 一次性
  • 可反复使用

第 8 章按应用程序

  • 尿失禁
  • 精神疾病
  • 膀胱癌、前列腺癌
  • 其他

第 9 章最终用户

  • 医院
  • 居家护理
  • 其他

第 10 章按地区划分

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第 11 章竞争格局

  • 竞争场景
  • 市场情况/份额分析
  • 併购分析

第 12 章外部导管市场 - 公司简介

  • B.Braun Melsungen AG
    • 公司概况
    • 按类型和描述划分的投资组合
    • 主要亮点
    • 财务摘要
  • ConvaTec Healthcare B S.a.r.l.
  • Coloplast Ltd.
  • Cook Medical
  • Teleflex Incorporated
  • Medline Industries Inc.
  • Medtronic PLC
  • C. R. Bard Inc.
  • Adapta Medical
  • Becton Dickson Company（LIST NOT EXHAUSTIVE）

第 13 章重要注意事项

第 14 章 DataM

简介目录
Product Code: DMPH3159

Market Overview

External Catheter Market was valued at USD XX million in 2021. It is forecasted to reach USD XX million by 2029, growing at a CAGR of 5.39% during the forecast period (2022-2029).

An external catheter is used in patients who are unable to do so normally to drain urine from the bladder. These catheters are meant to be used for a brief period. These are indicated for conditions such as urinary leakage, incontinence, and other problems with the bladder. Neurogenic bladder diseases, such as spinal cord injury, multiple sclerosis, or spina bifida, as well as non-neurogenic bladder diseases, may cause urinary incontinence. The periodic catheter is placed into the urethra, and urine is gathered into the collection bag with the help of the catheter hose. A catheter should be removed after emptying the bladder. The global external catheter market is projected to increase rapidly as the number of Catheter-associated Urinary Tract Infections, which are mainly correlated with indwelling catheter increases. In cases of urinary incontinence or urine leakage, external catheters are always the first option for patients who choose self-catheterization.

Market Dynamics: The rise in prevalence of urinary incontinence increase the demand for external catheter

The accidental discharge of urine is urinary incontinence. The control of the urinary sphincter is either reduced or weakened. It may develop as a result of stress factors like coughing and during and after breastfeeding and is more common in conditions like obesity. According to the American Urological Association, one-half to one-third of men and women in the United States suffer from urinary incontinence. In addition, urinary incontinence impacts nearly 200 million people worldwide. According to the Centers for Disease Control and Prevention, roughly 75% of UTIs obtained in the hospital were connected to a urinary catheter in the United States. According to the American Urology Association report, a quarter to a third of men and women in the U.S. suffer from urinary incontinence. About 33 million have overactive bladder (OAB), representing symptoms of urgency, frequency and with or without urge incontinence. OAB is a type of urinary incontinence, also called "urgency" incontinence. OAB affects more than 30% of men and 40% of women in the U.S. It adversely affects human life.

During the forecast era, the male external catheter market is expected to be driven by increasing demand for minimally invasive procedures and devices worldwide, as well as high awareness and affordability among people, especially in developing economies. Moreover, the rising prevalence of chronic illnesses, cardiovascular and urological conditions, and diabetes has increased catheter demand across the healthcare industry.

However, the leakage issue of the external catheter hampers the market growth. The frequent use of external catheters leads to leakages. As a result, doctors and health care providers favour choices such as intermittent catheters. The complications associated with using external catheters are a key factor expected to curtail the growth of the global market over the forecast period.

Market Segmentation: The disposable segment is projected to be the dominant segment in the market during the forecast period.

Based on the type, the external catheter market has been classified into disposable and repeatable.

The disposables segment dominated the global market in 2021, owing to the wide usage in hospitals where the demand per patient is temporary, and disposable catheters are designed to be thrown away after 24 hours. With patients having limited time in the hospitals, the disposable segment is bound to grow during the forecast period. Whereas the repeatable external catheter is expected to present considerable growth in the near future.

The global external catheter is segmented based on end-user, which includes hospitals, home care and others.

The hospital's segment held a significant market share during the forecast period, as most urinary incontinence and urinary infection cases are brought directly into the hospitals for treatment, supporting the segment growth during the forecast period. Moreover, home care is expected to project a considerable CAGR during the forecast period. Increasing investment in research and product development is expected to propel segment growth in the near future.

Geographical Penetration: North America is the dominating region during the forecast period.

Based on geography, the study analyzes the External Catheter market in the global market, including North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.

North America is holding a dominant position in the global external catheter market in 2021. In North America, the U.S. is expected to represent considerable growth during the forecast period. Well-established healthcare infrastructure and high healthcare expenditure per capita in the country results in a huge market for external catheter. Almost one out of every six men across the United States experiences some urinary incontinence. This increase the need for the catheter, which helps to drive market growth.

Moreover, Asia Pacific is expected to represent significant growth in terms of value during the forecast period. Significant investment in R&D and advanced product development is expected to propel regional market growth. The external catheter market for the Asia Pacific is expected to observe rapid growth over the forecast period, backed by the large population base, especially in India and China.

Competitive Landscape:

The external catheter market is highly competitive, owing to the presence of big medical companies. The key players which are contributing to the growth of the global market include B. Braun Melsungen AG, ConvaTec Healthcare B S.a.r.l, Coloplast Ltd.., Cook Medical., Teleflex Incorporated., Medline Industries Inc., Medtronic, C. R. Bard Inc, Adapta Medical, Becton Dickson Company, among others. The major players are adopting new product launch and expansion strategies for global growth in the external catheter market. In September 2020, Bard acquired female external catheter company named as PureWick for $30mm. This deals includes consumables and central supplies of the product. In September 2021, B.Braun Melsungen AG completed acquisition of Sterinova Inc. and owns 100% of the company. Sterinova Inc. continuously operated as a distinct subsidiary of B. Braun Melsungen AG. In November 2020, B.Braun Melsungen AG, one of the world's leading manufacturers of medical devices and pharmaceutical products and services and Grifols, a leading global producer of plasma-derived medicines and provider of technologies and services for hospitals, clinics and compounding centers announced global to enhance pharmacy production output and therapy safety. Together they find solutions for safe automated drug admixture and delivery. They focused on opportunities in Europe and gradually roll out the joint offering in other markets.

COVID-19 Impact: Stable growth on the global external catheter market.

The growth of the global demand for the external catheter is projected to stay stable throughout the emergence of the COVID-19 pandemic, as non-COVID-related healthcare facilities continue to run at a regular pace. The market for the external catheter is expected to stay stable in the wake of the current COVID-19 pandemic. Market participants are required to concentrate on solving the supply chain issues raised by the COVID-19 pandemic and designing appropriate solutions to resolve them.

The global external catheter market report would provide an access to approximately 61 market data tables, 52 figures and 170 pages

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet by Type
  • 3.2. Market Snippet by Application
  • 3.3. Market Snippet by End User
  • 3.4. Market Snippet by Region

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rise in Urinary Incontinence
      • 4.1.1.2. Increasing prevalence of Chronic diseases
    • 4.1.2. Restraints:
      • 4.1.2.1. Leakage issues in External Catheters
    • 4.1.3. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Value Chain Analysis
  • 5.4. PEST Analysis
  • 5.5. Pricing Analysis
  • 5.6. Regulatory Analysis
  • 5.7. Reimbursement Analysis
  • 5.8. Unmet Needs
  • 5.9. Patent Trends

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
  • 7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type Segment
  • 7.3. Market Attractiveness Index, By Type Segment
    • 7.3.1. Disposable*
      • 7.3.1.1. Introduction
      • 7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 7.3.2. Repeatable

8. By Application

  • 8.1. Introduction
  • 8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
  • 8.3. Market Attractiveness Index, By Application Segment
    • 8.3.1. Urinary Incontinence*
      • 8.3.1.1. Introduction
      • 8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 8.3.2. Mental illness
    • 8.3.3. Bladder and Prostate Cancer
    • 8.3.4. Others

9. By End User

  • 9.1. Introduction
  • 9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Segment
  • 9.3. Market Attractiveness Index, By End User Segment
    • 9.3.1. Hospitals*
      • 9.3.1.1. Introduction
      • 9.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 9.3.2. Home Care
    • 9.3.3. Others

10. By Region

  • 10.1. Introduction
  • 10.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
  • 10.3. Market Attractiveness Index, By Region
  • 10.4. North America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. U.S.
      • 10.4.6.2. Canada
      • 10.4.6.3. Mexico
  • 10.5. Europe
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. Germany
      • 10.5.6.2. U.K.
      • 10.5.6.3. France
      • 10.5.6.4. Italy
      • 10.5.6.5. Spain
      • 10.5.6.6. Rest of Europe
  • 10.6. South America
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.6.6.1. Brazil
      • 10.6.6.2. Argentina
      • 10.6.6.3. Rest of South America
  • 10.7. Asia Pacific
    • 10.7.1. Introduction
    • 10.7.2. Key Region-Specific Dynamics
    • 10.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.7.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.7.6.1. China
      • 10.7.6.2. India
      • 10.7.6.3. Japan
      • 10.7.6.4. Australia
      • 10.7.6.5. Rest of Asia Pacific
  • 10.8. Middle East and Africa
    • 10.8.1. Introduction
    • 10.8.2. Key Region-Specific Dynamics
    • 10.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.8.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. External Catheter Market- Company Profiles

  • 12.1. B. Braun Melsungen AG*
    • 12.1.1. Company Overview
    • 12.1.2. Type Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. ConvaTec Healthcare B S.a.r.l.
  • 12.3. Coloplast Ltd.
  • 12.4. Cook Medical
  • 12.5. Teleflex Incorporated
  • 12.6. Medline Industries Inc.
  • 12.7. Medtronic PLC
  • 12.8. C. R. Bard Inc.
  • 12.9. Adapta Medical
  • 12.10. Becton Dickson Company (LIST NOT EXHAUSTIVE)

13. Premium Insights

14. DataM Intelligence Analysis

  • 14.1. Appendix
  • 14.2. About Us and Services
  • 14.3. Contact Us